U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185204) titled 'Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study' on June 30.
Brief Summary: The goal of this study is to address the significant morbidity associated with preeclampsia diagnosed after delivery. All participants will undergo biomarker evaluation with soluble fms-like tyrosine kinase-1 and placental growth factor (sFlt-1/PlGF) ratio testing before delivery to assess the predictive ability of these biomarkers with new-onset postpartum preeclampsia. High-risk participants will be randomized to a bundle of care strategies aimed at early detection and management of postpartum preeclampsia.
Study Start Date: Oct....